ArticleScientific reports2026

Integrated pan cancer analysis with breast cancer validation identifies SEC13 homolog as prognostic biomarker and immunotherapy target.

Haojie Fu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.